There has been perhaps no greater advance in the prognosis of solid tumors in the last decade than for patients with metastatic melanoma. This is due to significant improvements in treatment based on two key components of melanoma tumor biology (1) the identification of driver mutations with therapeutic potential and (2) the mechanistic understanding of a tumor-specific immune response. With breakthrough findings in such a relatively short period of time, the treatment of patients with metastatic melanoma has become intensely personalized.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.soc.2023.12.017 | DOI Listing |
Publication Analysis
Top Keywords
patients metastatic
8
metastatic melanoma
8
precision oncology
4
melanoma
4
oncology melanoma
4
melanoma skin
4
skin cancer
4
cancer surgery
4
surgery greater
4
greater advance
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!